Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Accured Expenses (2022 - 2025)

CervoMed (CRVO) has disclosed Change in Accured Expenses for 9 consecutive years, with -$48096.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 123.59% to -$48096.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $834157.0 through Dec 2025, up 20.84% year-over-year, with the annual reading at $834157.0 for FY2025, 20.84% up from the prior year.
  • Change in Accured Expenses hit -$48096.0 in Q4 2025 for CervoMed, down from $454084.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.1 million in Q3 2024 to a low of -$440808.0 in Q2 2022.
  • Historically, Change in Accured Expenses has averaged $189321.9 across 4 years, with a median of $181119.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 1196.12% in 2023 and later tumbled 173.65% in 2024.
  • Year by year, Change in Accured Expenses stood at $158332.0 in 2022, then skyrocketed by 272.64% to $590016.0 in 2023, then plummeted by 65.44% to $203906.0 in 2024, then tumbled by 123.59% to -$48096.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for CRVO at -$48096.0 in Q4 2025, $454084.0 in Q3 2025, and $713608.0 in Q2 2025.